Cabozantinib S-malate

규격

1140909-48-3CAS 번호

691-711-0EC 번호

1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acidIUPAC 명칭

C32H30FN3O10화학식

635.6 g/mol분자량

Cabozantinib S-malate; 1140909-48-3; Cabozantinib malate; cabozantinib (S)-malate; Cabometyx; XL184; DR7ST46X58; CHEBI:72319; DTXSID60915949; RefChem:1080604; DTXCID501510465; Cabozantinib malate (XL184); Cabozantinib (S-malate); Cabozantinib L-Malate Salt; MFCD20923480; Cabozantinib s-malate [USAN]; C32H30FN3O10; 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid; N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; Cabometyx (TN); Cometriq (TN); Cabozantinib malate (JAN); Cabozantinib s-malate (USAN); CABOZANTINIB MALATE [JAN]; cabozantinib L-malate; UNII-DR7ST46X58; XL184 (S-malate);BMS-907351 (S-malate); RESNIBEN; XL-184 malate; Cabozantinib S-malate?; Cabozantinib S-Malate salt; XL184(Cabozantinib malate); MLS006010951; orb1226924; orb1307421; CHEMBL2103868; SCHEMBL29350740; SCHEMBL29881226; HFCFMRYTXDINDK-WNQIDUERSA-N; GLXC-10543; EX-A2819; EBC-17171; AKOS025401945; CABOZANTINIB S-MALATE [WHO-DD]; CCG-270301; CS-0201; FC64967; AC-27471; AS-75255; HY-12044; SMR004702755; SY105860; CABOZANTINIB S-MALATE [ORANGE BOOK]; SW218093-2; D10095; F861544; Q27139901; (2S)-2-Hydroxybutanedioic acid--N~1~-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (1/1); (2S)-2-hydroxybutanedioic acid; N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate); Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7- dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1- cyclopropanedicarboxamide; cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt; inverted exclamation mark N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-Hydroxysuccinate; N-(4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE MONO((2S)-2-HYDROXYBUTANEDIOATE); N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate; N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid동의어